Brief: Fusen Pharmaceutical Co Ltd Sees Loss Attributable With A Range From Rmb5 Million To Rmb9 Million For Six Months
19/08/2022 15:53
Fusen Pharmaceutical Co Ltd 1652.HK :
* FUSEN PHARMACEUTICAL CO LTD SEES LOSS ATTRIBUTABLE WITH A
RANGE
FROM RMB5 MILLION TO RMB9 MILLION FOR SIX MONTHS
* FUSEN PHARMACEUTICAL CO LTD - EXPECTED RESULT DUE TO
DECREASE
IN SALES OF GROUP'S MAJOR PRODUCTS, AMONG OTHERS
* FUSEN PHARMACEUTICAL CO LTD SEES DECREASE IN REVENUE BY
OVER
20% FOR SIX MONTHS
Source text for Eikon: ID:
Further company coverage: 1652.HK
Recent news on Fusen Pharmaceutical
See all newsBrief: Fusen Pharmaceutical Logs HY Loss Attributable RMB13.6 Million
Brief: Fusen Pharmaceutical Says Doxazosin Mesylate Extended-Release Tablets Approved For Marketing In China
Brief: Fusen Pharmaceutical Says Peramivir Injection First Neuraminidase Inhibitor Approved In China For Intravenous Influenza Treatment
Brief: Fusen Pharmaceutical Says Investors To Contribute RMB300 Mln For 34% Stake Subscription Of Henan Fusen Pharmaceutical
Brief: Fusen Pharmaceutical Says Piracetam Injection Approved For Marketing By NMPA